Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 292 Results
Age
Type
Conditions or Disease:

PhI/II Study ofREGN5668 Administered inCombw/Cemiplimab orREGN4018

Jill Tseng

  • OPEN TO ACCRUAL

A Phase 1 Study of NKX019 in Subjects with Immune-Mediated Disease

Tahseen Mozaffar

  • OPEN TO ACCRUAL

A prospective, multicenter, single arm, open-label, feasibility study to evaluate the safety

Pengbo Jiang

  • OPEN TO ACCRUAL

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topic

Maria Buethe

  • OPEN TO ACCRUAL

GenePHIT: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects with Non-Ischemic NYHA Cl

Felice Lin

  • OPEN TO ACCRUAL

A study to evaluate the efficacy and safety of frexalimab, SAR442970, or rilzabrutinib in participa

Ramy Hanna

  • OPEN TO ACCRUAL

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

Sanaz Attaripour Isfahani

  • OPEN TO ACCRUAL

Lung Cancer Screening of Family Members of Patients with Mutation-Driven Lung Cancer

Hari Keshava

  • OPEN TO ACCRUAL

An open-label study to assess safety, efficacy, and cellular kinetics of YTB323 in treatment-resista

Ali Habib

  • OPEN TO ACCRUAL

SingleArmPhIV EvalSafe&EfficOral Fruquintinib Tx RefracMetsColoRecCa Pa UnderrepresentedMinorityPop

Farshid Dayyani

  • OPEN TO ACCRUAL

PhIICemiplimabW/ChemoVsCemiplimabW/Chemo+OthCaTxPtsW/ResectNonSmalCelLungCa

Misako Nagasaka

  • OPEN TO ACCRUAL

PhII Adj w/Pembrolizumab After Resec of Recur/2nd Primary H&N SCC W/High Risk Features

Shirin Attarian

  • OPEN TO ACCRUAL

A randomized placebo-controlled study to evaluate the efficacy and safety of dapirolizumab pegol in

Sheetal Desai

  • OPEN TO ACCRUAL

A Prospective, Multicenter Study of the IndigoTM Aspiration System Seeking

Nadine Abi-Jaoudeh

  • OPEN TO ACCRUAL

RandomPhIIIBRAFTargetThe vsCabozantinibRAIRefractoryDifferentThyroidCa w/BRAFV600Em

Shirin Attarian

  • OPEN TO ACCRUAL